Full Text PA-95-053

MENTORED CLINICAL SCIENTIST DEVELOPMENT AWARD

NIH GUIDE, Volume 24, Number 15, April 28, 1995

PA NUMBER:  PA-95-053

P.T. 34

Keywords: 
  Biomedical Research, Multidiscipl 
  Clinical Medicine, General 


National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Dental Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke

Application Receipt Dates:  February 1, June 1, and October 1

PURPOSE

The purpose of the Mentored Clinical Scientist Development Award
MCSDA is to support the development of outstanding clinician research
scientists.  This mechanism provides specialized study for clinically
trained professionals who are committed to a career in research and
have the potential to develop into independent investigators.  The
award supports a three, four, or five year period of supervised
research experience that may integrate didactic studies with
laboratory or clinically-based research.  The proposed research
should have both intrinsic research importance and be a suitable
vehicle for learning the methodology, theories, and
conceptualizations necessary for a well trained independent
researcher.

Because of the focus on progression to independence, the prospective
candidate should propose a period of study and development consistent
with this goal and his or her previous research and clinical
experience.  For example, a candidate with limited experience in a
given field of research may find a phased developmental program
lasting for five years which includes a designated period of didactic
training and supervised research experience the most efficient means
of attaining independence.  A candidate with substantial previous
research experience may require a shorter award period appropriate
for the transition to independence.  The entire program should be
comparable in scope and rigor to meeting the requirements for an
advanced research degree.

This award replaces the Clinical Investigator Award (K08), the
Physician Scientist Award (K11), the Dentist Scientist Award (K15),
and the Scientist Development Award for Clinicians (K20).
Individuals who were eligible to apply for one of these awards are
now directed to apply for an MCSDA.  Therefore, this program
announcement supersedes all previous K08, K11, K15 and K20 program
announcements and competing applications for these awards will no
longer be accepted.  Existing policies and provisions will remain in
effect for current K08, K11, K15 and K20 recipients until completion
of the non-competing years of their career development program.

The NIH institutes and centers implement this award in different ways
to accomodate the career needs of researchers in fields within their
missions.  For example the National Institute of Dental Research
(NIDR) requires that, in most situations, candidates must pursue a
program that includes didactic and supervised basic or behavioral
science research experiences that result in the Ph.D. degree.  The
NIDR may, under specific circumstances, provide support under this
program for the development of advanced clinical knowledge and skills
in either a recognized clinical specialty or equivalent dental
clinical discipline.  Therefore, the prospective candidate must have
a D.D.S. or an equivalent degree but need not have started
postgraduate training, such as in a clinical specialty or general
practice dental residency.  However, preference will be given to
applicants with advanced training in general or specialty practice.
Dentists without advanced clinical knowledge and skills are eligible
for the MCSDA but are encouraged to seek appointments to the Mentored
Clinical Scientist Development Program Award (K12).  All applicants
are strongly encouraged to contact the prospective awarding component
to discuss issues of eligibility and the specific provisions of this
award.

The NIH recently reviewed its career awards (K) used to develop the
research capabilities of clinicians and other scientists needed to
carry out the nation's research mission in the biomedical and
behavioral sciences.  This evaluation resulted in several changes:
(1) the total number of K mechanisms were reduced from 19 to six; (2)
the review criteria were refined to clarify the career development
goals of the K award; and (3) K award applications will be assigned
to initial review groups managed by the prospective funding institute
or center to which the application has been assigned.

HEALTHY PEOPLE 2000

The Public Health Service is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas.  This program
announcement, Mentored Clinical Scientist Development Award, is
related to the priority area of human resource development.
Potential candidates may obtain a copy of "Healthy People 2000" (Full
Report:  Stock No. 017-001-00474-0 or Summary Report:  Stock No.
017-001-00473-1) from the Superintendent of Documents, Government
Printing Office, Washington, DC 20402-9325 (telephone 202/783-3238).

ELIGIBILITY REQUIREMENTS

The candidate must have a clinical degree or its equivalent, must
have initiated postgraduate clinical training, must identify a mentor
with extensive research experience, and must be willing to spend a
minimum of 75 percent of full-time professional effort conducting
research and research career development.

Applications may be submitted, on behalf of candidates, by domestic,
non-Federal organizations, public or private, such as medical,
dental, or nursing schools or other institutions of higher education.
Minorities and women are encouraged to apply. Candidates must be U.S.
citizens or noncitizen nationals, or must have been lawfully admitted
for permanent residence and possess an Alien Registration Receipt
Card (I-151 or I-551) or some other verification of legal admission
as a permanent resident.  Noncitizen nationals, although not U.S.
citizens, owe permanent allegiance to the U.S.  They are usually born
in lands that are not states but are under U.S. sovereignty,
jurisdiction, or administration.  Individuals on temporary or student
visas are not eligible.

Former principal investigators on NIH research project (R01), FIRST
Awards (R29), sub-projects of program project (P01) or center grants
(P50), or the equivalent, are not eligible.  A candidate for the
MCSDA may not concurrently apply for any other PHS award that
duplicates the provisions of this award nor have another application
pending award.  MCSDA recipients are encouraged to apply for
independent research grant support during the period of this award.

MECHANISM OF SUPPORT

Awards in response to this program announcement will use the K08
mechanism.  Planning, direction, and execution of the program will be
the responsibility of the candidate and her/his mentor on behalf of
the applicant institution.  The project period may be for three, four
or five years and will depend upon the number of years of prior
research experience, the need for additional experiences to achieve
independence, and the policy of each particular institute or center.
Awards are not renewable.

RESEARCH OBJECTIVES

A.  Environment: The institution must have a well-established
research and clinical career development programs and qualified
faculty in clinical and basic research to serve as mentors.  The
institution must be able to demonstrate a commitment to the
development of the candidate as a productive, independent
investigator.  And, the candidate, mentor and institution must be
able to describe a multi- disciplinary career development program
that will maximize the use of relevant research and educational
resources.

B.  Program: The award provides three to five consecutive 12 month
appointments.  At least 75 percent of the recipient's full-time
professional effort must be devoted to the program and the remainder
devoted to other clinical and teaching pursuits consonant with the
objectives of the award.  The basic science component must develop
knowledge and research skills in scientific areas relevant to the
career goals of the candidate.

C.  Mentor(s):  The recipient must receive appropriate mentoring
throughout the three to five year program.  Where feasible, women and
minority mentors should be involved as role models.

D.  Allowable Costs:

1.  Salary:  The NIH will provide salary and fringe benefits for the
K recipient.  The salary limits are not uniform throughout the NIH
and are determined independently by each component of the NIH.
Therefore, prospective candidates should contact the NIH component to
which the application is targeted to ascertain the maximum
contribution to the candidate's salary.

The institution may supplement the NIH contribution up to a level
that is consistent with the institution's salary scale; however,
supplementation may not be from Federal funds unless specifically
authorized by the Federal program from which such funds are derived.
In no case, may PHS funds be used for salary supplementation.
Institutional supplementation of salary must not require extra duties
or responsibilities that would interfere with the purpose of the
MCSDA.  Under expanded authorities, however, institutions may
rebudget funds within the total costs awarded to cover salaries
consistent with the institution's salary scale.

The total salary requested must be based on a full-time, 12-month
staff appointment.  It must be consistent both with the established
salary structure at the institution and with salaries actually
provided by the institution from its own funds to other staff members
of equivalent qualifications, rank, and responsibilities in the
department concerned.  If full-time, 12-month salaries are not
currently paid to comparable staff members, the salary proposed must
be appropriately related to the existing salary structure.

2.  Research Development Support: Most awarding components at the NIH
will provide up to $20,000 per year is allowed for the following
expenses:  (a) tuition, fees, and books related to career
development; (b) research expenses, such as supplies, equipment and
technical personnel; (c)  travel to research meetings or training;
(d) statistical services including personnel and computer time.  The
amount of research development support is not uniform across all
awarding components.  Prospective candidates should contact the NIH
component to which the application is targeted to ascertain the
maximum amounts available.

The National Institute of Dental Research and the National Heart,
Lung, and Blood INstitute will provide up to $15,000 for research
development support.  The National Institute of Mental Health will
provide up to $50,000 for research development support.

3.  Ancillary Personnel Support: Salary for mentors, secretarial and
administrative assistance, etc., is not allowed.

4.  Indirect costs: Indirect costs will be reimbursed at 8 percent of
modified total direct costs, or at the actual indirect cost rate,
whichever is less.

E.  Evaluation:  In carrying out its stewardship of human resource
related programs, the NIH may begin requesting information essential
to an assessment of the effectiveness of this program.  Accordingly,
recipients are hereby notified, that they may be contacted after the
completion of this award for periodic updates on various aspects of
their employment history, publications, support from research grants
or contracts, honors and awards, professional activities, and other
information helpful in evaluating the impact of the program.

F.  Other Income: Fees resulting from clinical practice, professional
consultation, or other comparable activities required by the research
and research-related activities of this award may not be retained by
the career award recipient.  Such fees must be assigned to the
grantee institution for disposition by any of the following methods:

The funds may be expended by the grantee institution in accordance
with the NIH policy on supplementation of career award salaries and
to provide fringe benefits in proportion to such supplementation.
Such salary supplementation and fringe benefit payments must be
within the established policies of the grantee institution.

The funds may be used for health-related research purposes.

The funds may be paid to miscellaneous receipts of the U.S. Treasury.
Checks should be made payable to the Department of Health and Human
Services, NIH and forwarded to the Director, Division of Financial
Management, NIH, Bethesda, Maryland 20892.  Checks must identify the
relevant award account and reason for the payment.

Awardees may retain royalties and fees for activities such as
scholarly writing, service on advisory groups, or honoraria from
other institutions for lectures or seminars, provided these
activities remain incidental and provided that the retention of such
pay is consistent with the policies and practices of the grantee
institution.

Usually, funds budgeted in an NIH supported research or research
training grant for the salaries or fringe benefits of individuals,
but freed as a result of a career award, may not be rebudgeted.  The
awarding component will give consideration to approval for the use of
released funds only under unusual circumstances.  Any proposed
retention of funds released as a result of a career award must
receive prior written approval of the NIH awarding component.

G.  Special Leave: Leave to another institution, including a foreign
laboratory, may be permitted if directly related to the purpose of
the award.nly local, institutional approval is required if such leave
does not exceed 3 months.  For longer periods, prior written approval
of the NIH funding component is required.  To obtain prior approval,
the award recipient must submit a letter to the NIH describing the
plan, countersigned by his or her department head and the appropriate
institutional official.  A copy of a letter or other evidence from
the institution where the leave is to be taken must be submitted to
assure that satisfactory arrangements have been made.  Support from
the career award will continue during such leave.

Leave without award support may not exceed 12 months.  Such leave
requires the prior written approval of the NIH funding component and
will be granted only in unusual situations.  Support from other
sources is permissible during the period of leave.  Such leave does
not reduce the total number of months of program support for which an
individual is eligible.  Parental leave will be granted consistent
with the policies of the NIH and the grantee institution.

H.  Termination or Change of Institution: When a grantee institution
plans to terminate an award, the NIH funding component must be
notified in writing at the earliest possible time so that appropriate
instructions can be given for termination.  If the individual is
moving to another eligible institution, career award support may be
continued provided:

A new career award application is submitted by the new institution;

The period of support requested is no more than the time remaining
within the existing award period; and

The new application is submitted far enough in advance of the
requested effective date to allow the necessary time for review.

The funding component may require a review by an initial review group
and/or the appropriate National Advisory Council or Board.
Alternatively, review may be carried out by staff within the NIH
funding component depending upon the circumstances.

The Director of the NIH may discontinue an award upon determination
that the purpose or terms of the award are not being fulfilled.  In
the event an award is terminated, the Director of the NIH shall
notify the grantee institution and career award recipient in writing
of this determination, the reasons therefor, the effective date, and
the right to appeal the decision.

A final progress report, invention statement, and Financial Status
Report are required upon either termination of an award or
relinquishment of an award in a change of institution situation.

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN
SUBJECTS

It is the policy of the NIH that women and members of minority groups
and their subpopulations must be included in all NIH supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification is provided
that inclusion is inappropriate with respect to the health of the
subjects or the purpose of the research.  This new policy results
from the NIH Revitalization Act of 1993 (Section 492B of Public Law
103-43) and supersedes and strengthens the previous policies
(Concerning the Inclusion of Women in Study Populations, and
Concerning the Inclusion of Minorities in Study Populations) which
have been in effect since 1990.  The new policy contains some new
provisions that are substantially different from the 1990 policies.
All investigators proposing research involving human subjects should
read the "NIH Guidelines For Inclusion of Women and Minorities as
Subjects in Clinical Research," which have been published in the
Federal Register of March 28, 1994 (FR 59 14508-14513), and reprinted
in the NIH GUIDE FOR GRANTS AND CONTRACTS of March 18, 1994, Volume
23, Number 11.

Investigators may obtain copies from these sources or from the
program staff or contact person listed below.  Program staff may also
provide additional relevant information concerning the policy.

APPLICATION PROCEDURES

This is a generic program announcement for the MCSDA.  Therefore, all
candidates are strongly encouraged to contact the staff person in the
relevant institute or center listed under INQUIRIES.  Such contact
should occur early in the planning phase of application preparation.
Such contact will help ensure that applications are responsive to the
career development goals and policies of the individual institute or
center.

Applications are to be submitted on form PHS 398 (rev. 9/91) and will
be accepted on or before the receipt deadlines indicated in the
application kit (February 1, June 1 and October 1).  Forms are
available at most institutional offices of sponsored research and
from the Office of Grants Information, Division of Research Grants,
NIH, 5333 Westbard Avenue, Room 449, Bethesda, MD 20892, telephone
301/710-0267.

The application must address the following issues:

Candidate

o  Describe the candidate's commitment to a career in biomedical or
behavioral research

o  Establish the candidate's potential to develop into an independent
investigator.

o  Describe immediate and long-term career objectives, explaining how
the award will contribute to their attainment.

o  Letters of recommendation.  Three sealed letters of recommendation
addressing the candidate's potential for a research career must be
included as part of the application.

Career Development Plan

o  Describe the career development plan incorporating consideration
of the candidate's goals and prior experience.  It should describe a
systematic plan to obtain the necessary basic biomedical or
behavioral science background and research experience to launch an
independent research career.  More junior candidates with little
previous research experience may require a phased developmental
period in which the first year(s) of the award are largely of a
didactic nature followed by a period of intense, supervised research
experience.  Candidates with more experience at the time of
application may need a shorter developmental period and may already
have an adequate basic science background.  In any case, the career
development plan must be tailored to the needs of the candidate and
the ultimate goal of independence as a researcher.

o  Candidates seeking support from NIDR should also include a
description of their plan to obtain the necessary clinical training

o  Candidates must describe plans to receive Instruction in the
responsible conduct of research.  These plans must detail the
proposed subject matter, format, frequency, and duration of
instruction.  No award will be made if an application lacks this
component.

Research Plan

o  Describe the research plan and the use of a basic or clinical
science approach to a biomedical or behavioral problem.  The research
plan must be described as outlined in form PHS 398 including sections
on the  Specific Aims, Background and Significance, Progress Report/
Preliminary Studies, Research Design and Methods.  The candidate
should consult with the mentor regarding the development of this
section.

Mentor's Statement

o  The application must include information on the mentor(s)
including information on research qualifications and previous
experience as a research supervisor.  The applications must also
include information to describe the nature and extent of supervision
that will occur during the proposed award period.

Environment and Institutional Commitment

o  The sponsoring institution must document a strong, well-
established research program related to the candidate's area of
interest including a high-quality research environment with staff
capable of productive collaboration with the candidate.  The
sponsoring institution also must provide a statement of commitment to
the candidate's development into a productive, independent
investigator.

Budget

o  Budget requests must be provided according to the instructions in
form PHS 398.  The request for tuition and fees, books, travel,
research development support, etc., must be justified and specified
by category.

To identify the application as a response to this program
announcement, check "YES" on item 2a of page 1 of the application and
enter "PA-95-053, Mentored Clinical Scientist Development Award" and
the name of the NIH institute or center that you would like your
application to be assigned for funding.

Submit a signed, typewritten original of the application with
Checklist, and five signed photocopies, in one package to:

Division of Research Grants
National Institutes of Health
6701 Rockledge Drive, Room 1040  MSC 7710
Bethesda, MD  20892-7710
Bethesda, MD  20817 (for express/courier service)

REVIEW CONSIDERATIONS

Applications will be reviewed for completeness by the Division of
Research Grants and for responsiveness to this program announcement
by the appropriate institute or center staff.  Incomplete or
nonresponsive applications will be returned to the applicant without
further consideration.  Applications that are complete and responsive
to the program announcement will be evaluated for scientific and
technical merit by an appropriate peer review group convened in
accordance with the standard NIH peer review procedures.  As part of
the initial merit review, all applications will receive a written
critique and undergo a process in which only those applications
deemed to have the highest scientific merit, generally the top half
of applications under review, will be discussed, assigned a priority
score, and receive a second level review by he appropriate national
advisory council or board.

The following review criteria will be applied:

Candidate

o  Quality of the candidate's academic and clinical record,

o  Potential to develop as an independent researcher;

o  Commitment to a research career; and

o  Likelihood that the plan will contribute substantially to the
achievement of scientific independence.

Career Development Plan

o  Likelihood that the career development plan will contribute
substantially to the scientific development of the candidate;

o  Appropriateness of the content, the phasing, and the proposed
duration of the career development plan for achieving scientific
independence;

o  Consistency of the career development plan with the candidate's
career goals; and

o  Quality of the proposed training in responsible conduct of
research.

Research Plan

Reviewers recognize that an individual with limited research
experience is less likely to be able to prepare a research plan with
the breadth and depth of that submitted by a more experienced
investigator.  Although it is understood that K08 applications do not
require the level of detail necessary in regular research grant
proposals, a fundamentally sound research plan must be provided.  In
general, less detail is expected with regard to research planned for
the later years of the award, but the application should outline the
general goals for these years.

o  Appropriateness of the research plan to the stage of research
development and as a vehicle for developing the research skills as
described in the career development plan;

o  Scientific and technical merit of the research question, design
and methodology;

o  Relevance of the proposed research to the candidate's career
objectives; and

o  Adequacy of the plan's attention to gender and minority issues.

Mentor

o  Appropriateness of mentor's research qualifications in the area of
this application;

o  Quality and extent of mentor's proposed role in providing guidance
and advice to the candidate;

o  Previous experience in fostering the development of researchers;
and

o  History of research productivity and support.

Environment and Institutional Commitment

o  Applicant institution's commitment to the scientific development
of the candidate and assurances that the institution intends the
candidate to be an integral part of its research program;

o  Adequacy of research facilities and training opportunities;

o  Quality and relevance of the environment for scientific and
professional development of the candidate; and

o  Applicant institution's commitment to an appropriate balance of
research and clinical responsibilities.

Budget

o  Justification of the requested budget in relation to career
development goals and research aims.

AWARD CRITERIA

The institute or center will notify the applicant of the board or
council's action shortly after its meeting.  Funding decisions will
be made based on the recommendations of the initial review group and
council/board, the need for research personnel in specific program
areas, and the availability of funds.

INQUIRIES

Written and telephone inquiries concerning this program announcement
are strongly encouraged especially during the planning phase of the
application.  Below is a listing of each institute's or center's
program or grants management contacts.

Dr. Robin A. Barr
Office of Extramural Affairs
National Institute on Aging
7201 Wisconsin Avenue, Room 2C218, MSC 9205
Bethesda, MD  20892-9205
Telephone:  (301) 496-9322
FAX:  (301) 402-9245
Email:  [email protected]

Dr. Ernestine D. Vanderveen, Ph.D.
Division of Basic Research
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard, Suite 402 MSC 7003
Bethesda, MD  20892-7003
Telephone:  (301) 443-1273
FAX:  (301) 594-0673
Email:  [email protected]

Ms. Frances Cotter
Division of Clinical and Prevention Research
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard, Suite 505 MSC 7003
Bethesda, MD  20892-7003
Telephone:  (301) 443-1207
FAX:  (301) 443-8744
Email:  [email protected]

Dr. Mary C. Dufour
Division of Biometry and Epidemiology
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard, Suite 514 MSC 7003
Bethesda, MD  20892-7003
Telephone:  (301) 443-4897
FAX:  (301) 443-8614
Email:  [email protected]

Dr. Milton Hernandez
Office of Scientific Training and Manpower Development
National Institute of Allergy and Infectious Diseases
Solar Building, Room 3C21
Bethesda, MD  20892
Telephone:  (301) 496-7291
FAX:  (301) 402-0369
Email:  [email protected]

Richard Lymn, Ph.D.
Extramural Programs
National Institute on Arthritis and Musculoskeletal and Skin Diseases
45 Center Drive, Room 5AS-49E  MSC 6500
Bethesda, MD  20892-6500
Telephone:  (301) 594-5128
FAX:  (301) 480-4543
Email:  [email protected]

Dr. John Schneider or Dr. Andrew Vargosko
Division of Cancer Biology, Diagnosis, and Centers
National Cancer Institute
Executive Plaza North, Room 520
Bethesda, MD  20892
Telephone:  (301) 496-8580
FAX:  (301) 402-4472
Email:  [email protected]  or
[email protected]

Hildegard Topper
Special Assistant to the Deputy Director
National Institute of Child Health and Human Development Building 31,
Room 2A-03
Bethesda, MD  20892
Telephone:  (301) 496-0104
FAX:  (301) 402-1104
Email: [email protected]

Daniel Sklare, Ph.D.
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400B-13
Bethesda, MD  20892
Telephone:  (301) 496-1804
FAX:  (301) 402-6251
Email:  [email protected]

Dr. James A. Lipton
Special Assistant for Training and Career Development
National Institute of Dental Research
Natcher Building, Room 4AN.18J
Bethesda, MD  20892
Telephone:  (301) 594-2618
FAX:  (301) 480-8319
Email:  [email protected]

Ronald Margolis, Ph.D.
Division of Diabetes, Endocrinology, and Metabolic Diseases National
Institute of Diabetes and Digestive and Kidney Diseases 45 Center
Drive, Room 5AN-12J, MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-8819
FAX:  (301) 480-3503
Email:  [email protected]

Charles Rodgers, Ph.D.
Division of Kidney, Urologic, and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases 45
Center Drive, Room 6AS-19J  MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-7717
FAX:  (301) 480-3510
Email:  [email protected]

Judith Podskalny, Ph.D.
Division of Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases 45
Center Drive, Room 6AN-12E, MSC 6600
Bethesda, MD  20892-6600
Telephone:  (301) 594-8876
FAX:  (301) 480-8300
Email:  [email protected]

Timothy P. Condon, Ph.D.
Office of Science Policy, Education, and Legislation
National Institute on Drug Abuse
Parklawn Building, Room 10A-55
Rockville, MD  20857
Telephone:  (301) 443-6072
FAX:  (301) 443-6277
Email:  [email protected]

Charles W. Sharp, Ph.D.
Division of Basic Research
National Institute on Drug Abuse
Parklawn Building, Room 10A-31
Rockville, MD  20857
Telephone:  (301) 443-1887
FAX:  (301) 594-6043
Email:  [email protected]

Arthur Horton, Ed.D.
Division of Clinical Research
National Institute on Drug Abuse
Parklawn Building, Room 10A-30
Rockville, MD  20857
Telephone:  (301) 443-4060
FAX:  (301) 443-2317
Email:  [email protected]

Ann Blanken
Division of Epidemiology and Prevention Research
National Institute on Drug Abuse
Parklawn Building, Room 9A-55
Rockville, MD  20857
Telephone:  (301) 443-6543
FAX:  (301) 443-9847
Email:  [email protected]

Jamie Biswas, Ph.D.
Medications Development Division
National Institute on Drug Abuse
Parklawn Building, Room 11A-55
Rockville, MD  20857
Telephone:  (301) 443-5280
FAX:  (301) 443-2599
Email:  [email protected]

Dr. Michael Galvin
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
P.O. Box 12233, MD 3-02
Research Triangle Park, NC  27709
Telephone:  (919) 541-7825
FAX:  (919) 541-2843
Email: [email protected]

Dr. Maria Giovanni
National Eye Institute
Building 31, Room 6A48
Bethesda,  MD  20892
Telephone:  (301) 496-0484
FAX:  (301) 402-0528
Email:  [email protected]

Thomas Blaszkowski, Ph.D.
Division of Epidemiology and Clinical Applications
National Heart, Lung, and Blood Institute
Federal Building, Room 208A
Bethesda, MD  20892
Telephone:  (301) 496-1841
FAX:  (301) 480-1455
Email:  [email protected]

Michael Commarato, Ph.D.
Division of Heart and Vascular diseases
National Heart, Lung, and Blood Institute
7550 Wisconsin Avenue, Room 3C04
Bethesda, MD  20892
Telephone:  (301) 496-1724
FAX:  (301) 402-2043
Email:  [email protected]

Joyce Creamer
Division of Blood diseases and Resources
National Heart, Lung, and Blood Institute
7550 Wisconsin Avenue, Room 5C02
Bethesda, MD  20892
Telephone:  (301) 496-8388
FAX:  (301) 480-0867
Email:  [email protected]

James Kiley, Ph.D.
National Center for Sleep Disorders Research
National Heart, Lung, and Blood Institute
Building 31, Room 4A11
Bethesda, MD  20892
Telephone:  (301) 496-7443
FAX:  (301) 496-7508
Email:  [email protected]

Mary Reilly
Division of Lung Diseases
National Heart, Lung, and Blood Institute
Westwood Building, Room 640
Bethesda, MD  20892
Telephone:  (301) 594-7466
FAX:  (301) 594-7487
Email:  [email protected]

George T. Niederehe, Ph.D.
Division of Clinical and Treatment Research
National Institute of Mental Health
5600 Fishers Lane, Room 18-105
Rockville, MD  20857
Telephone:  (301) 443-3264
FAX:  (301) 594-6784
Email:  [email protected]

Kenneth G. Lutterman, Ph.D.
Division of Epidemiology and Services Research
National Institute of Mental Health
5600 Fishers Lane, Room 10-95
Rockville, MD  20857
Telephone:  (301) 443-3373
FAX:  (301) 443-4045
Email:  [email protected]

Henry Khachaturian, Ph.D.
Division of Neuroscience and Behavioral Science
National Institute of Mental Health
5600 Fishers Lane, Room 11-103
Rockville, MD  20857
Telephone:  (301) 443-8033
Email:  [email protected]

Leonard Mitnick, Ph.D.
Office of AIDS Programs
National Institute of Mental Health
5600 Fishers Lane, Room 10-75
Rockville, MD  20857
Telephone:  (301) 443-9719
Email:  [email protected]

Mr. Edward Donohue
Division of Extramural Activities
National Institute of Neurological Disorders and Stroke Federal
Building, Room 1016A
Bethesda, MD  20892
Telephone:  (301) 496-4188
Email:  [email protected]

AUTHORITY AND REGULATIONS

The Mentored Clinical Scientist Development Awards are made under the
authority of Title III, Section 301 of the Public Health Service
(PHS) Act as amended (Public Law 78-410, as amended, 42 USC 241).
The Code of Federal Regulations, Title 42 Part 52, and Title 45 part
74, are applicable to this program.  This program is described in the
Catalog of Federal Domestic Assistance No. 93.121.  This program is
not subject to the intergovernmental review requirements of Executive
Order 12372 or Health Systems Agency review.

The PHS strongly encourages all grant and contract recipients to
provide a smoke-free workplace and promote the non-use of all tobacco
products.  In addition, Public Law 103-227, the Pro-Children Act of
1994, prohibits smoking in certain facilities (or in some cases, any
portion of a facility) in which regular or routing education,
library, day care, health care or early childhood development
services are provided to children.  This is consistent with the phs
mission to protect and advance the physical and mental health of the
american people.

.

Return to PA Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)